Deep Health AI India pays ₹2.85 crore advance for Pune land acquisition

1 min read     Updated on 13 Jul 2026, 10:21 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Deep Health AI India Limited paid an aggregate advance of ₹2.85 crore across 10 tranches for 49,100 sq. mtr of land in Pune, following an MoU dated March 06, 2026. The acquisition is intended for developing a naturopathy and holistic rejuvenation centre focused on organic wellness. The company noted a delay in disclosing the transaction due to an oversight.

powered bylight_fuzz_icon
45507077

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Limited has remitted an aggregate advance payment of ₹2.85 crore towards the proposed acquisition of land in Pune. The company entered into a Memorandum of Understanding (MoU) with M/s. Elegant Floriculture & Agrotech (India) Limited on March 06, 2026, for the purchase of a plot measuring 49,100 sq. mtr situated at Gat No. 358, Village Mouje Kashal, Taluka – Maval, District Pune. The advance was paid in 10 tranches, with the last tranche disbursed on June 06, 2026.

The proposed acquisition aims to establish a naturopathy centre and a holistic rejuvenation centre. The project will include the cultivation of medicinal plant species, with a strategic focus on organic and herb-based wellness and agro-tourism to promote preventive healthcare.

The company disclosed that the intimation regarding this transaction was inadvertently delayed due to an oversight. Upon noticing the omission, the management took immediate steps to make the necessary disclosure to the exchange.

Transaction Details

Particulars Details
Vendor M/s. Elegant Floriculture & Agrotech (India) Limited
Land Area 49,100 sq. mtr
Location Gat No. 358, Village Mouje Kashal, Taluka – Maval, District Pune
Total Advance Paid ₹2.85 crore
Payment Tranches 10
Last Payment Date June 06, 2026
MoU Date March 06, 2026

The disclosure was submitted by Narayan Singh Rathore, Managing Director of Deep Health AI India Limited.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%-3.32%-9.73%-61.65%-51.66%+85.45%

What is the projected timeline for the completion of the naturopathy and holistic rejuvenation centres?

How does the company plan to fund the remaining construction and operational costs beyond the initial land acquisition?

What revenue models are expected to drive the agro-tourism and preventive healthcare segments?

Deep Health AI India Ltd revises FY26 audit report

2 min read     Updated on 13 Jul 2026, 01:47 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Deep Health AI India Ltd submitted a revised audit report for FY26 to include entity names in the consolidated financial statements, confirming no change in financial results. The auditor flagged key matters regarding an exceptional loss on a proposed acquisition and the deviation in utilization of Rights Issue proceeds.

powered bylight_fuzz_icon
45476205

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Ltd submitted a revised audit report for the financial year ended March 31, 2026, to the BSE. The revision incorporates the names of entities covered under the Consolidated Financial Statements, which were inadvertently omitted in the previous filing. The company clarified that there is no change in the audited standalone and consolidated financial results as a result of this update.

The Board of Directors had approved the audited standalone and consolidated financial results at its meeting held on May 29, 2026. The subsequent observation regarding the omission of entity names in the Auditor's Report prompted the filing of the revised document. The company stated that the omission was purely inadvertent and does not impact the financial results or the audit opinion.

The independent auditor, VRSK & Co. LLP, highlighted two key audit matters in the report. The first concerned accounting implications arising from a proposed acquisition of Oasis Ceramics Pvt. Ltd. under the Insolvency and Bankruptcy Code, 2016. The company recognised an exceptional loss related to the amount paid and a bank guarantee of ₹3.21 crore that was invoked due to delays in payment timelines.

The second key audit matter addressed the utilization of proceeds from a Rights Issue. The company raised ₹39.97 crore during the year but utilised only ₹2.5 crore towards the objects stated in the Letter of Offer. The balance amount of ₹37.47 crore was utilised for other purposes, primarily investment in securities, a deviation that was ratified by shareholders on January 22, 2026.

Utilization of Rights Issue Proceeds

Nature of Securities Purpose for which funds were raised Total Amount raised Amount utilized for the other purpose Unutilized balance as at the Balance sheet date Remarks
Equity Shares Acquisition of Oasis Ceramics Private Limited 30,00,000 30,00,000 0 Entire amount diverted to investment in Equity.
Equity Shares To meet General corporate purposes 9,62,760 7,61,260 0 Partially utilised; balance diverted to investment in Equity and share issue expense.
Equity Shares To meet the expenses of the Issue 35,000 0 0 Excess Utilization Rs 13.86 Lacs

The auditor affirmed that the internal financial controls over financial reporting were adequate and operating effectively as of March 31, 2026. The revised report was signed by Suresh G. Kothari, Partner at VRSK & Co. LLP, on May 29, 2026.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%-3.32%-9.73%-61.65%-51.66%+85.45%

What is the expected timeline for the completion of the Oasis Ceramics acquisition under the Insolvency and Bankruptcy Code?

How will the significant deviation in Rights Issue proceeds utilization impact the company's ability to raise future capital?

What specific securities did the company invest the diverted ₹37.47 crore in, and what is the current valuation of those investments?

More News on Deep Health AI

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-51.66%